Results 111 to 120 of about 127,735 (256)

Comparative and variance analysis of activity of glutation dependent enzymes in loach Misgurnus fossilis L. embryos under the influence of flurenizyd

Біофізичний вісник, 2016
The aim of work was to study the influence of flurenizyd (antimicrobial, antituberculosis, antichlamydia, immunomodulatory, antioxidant, hepatoprotective, anti-inflammatory medicine) on the antioxidant homoeostasis of loach embryos (Misgurnus fossilis L.)
Н. О. Боднарчук, Н. П. Гарасим, Л. І. Петрух, Д. І. Санагурський   +3 more
doaj  

Inhibition Analysis and High-Resolution Crystal Structure of Mus musculus Glutathione Transferase P1-1. [PDF]

Biomolecules, 2023
Kupreienko O, Pouliou F, Konstandinidis K, Axarli I, Douni E, Papageorgiou AC, Labrou NE.   +6 more
europepmc   +1 more source

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

Molecular characteristics of glutathione transferase gene family in a neglect medical Spirometra tapeworm. [PDF]

Front Vet Sci, 2022
Chen WQ, Liu SS, Cheng C, Cui J, Wang ZQ, Zhang X.   +5 more
europepmc   +1 more source

A nanoplatform that induces dual‐amino acid deprivation to reverse tumor immunosuppression and enhance metabolic immunotherapy

BMEMat, EarlyView.
ZIF‐8‐based nanoparticles co‐delivering CB‐839 (glutaminase inhibitor) and 1‐MT (IDO1 inhibitor), dual‐targeting glutamine/tryptophan metabolism to induce immunogenic cell death, activate STING, block kynurenine production, reverse immunosuppression, and enhance cancer immunotherapy to suppress primary/distant tumors.
Wenli Ning, Yunhan Sun, Mingyang Li, Shilu Liu, Fangjie Yi, Hongfei Wang, Ruibing Bai, Dongdong Liu, Fen Zhao, Guiqiang Zhang, Xiao Fu   +10 more
wiley   +1 more source

Myricetin as a Potential Adjuvant in Chemotherapy: Studies on the Inhibition of Human Glutathione Transferase A1-1. [PDF]

Biomolecules, 2022
Alqarni MH, Foudah AI, Muharram MM, Alam A, Labrou NE.   +4 more
europepmc   +1 more source

Enhanced strategies for cuproptosis‐like death in bacterial infection treatment

BMEMat, EarlyView.
This review summarizes and examines the molecular mechanisms underlying cuproptosis‐like death. Furthermore, multi‐strategy efficacy enhancement and potential enhancement approaches are analyzed. Abstract Copper, a classical antibacterial metal, has long been of interest and widely used in medical and public health applications.
Wenqi Wang, Bolong Xu, Ruiyuan Zhu, Hengshuo Gui, Tian Xia, Shaokai Liu, Huiyu Liu, Xianwen Wang   +7 more
wiley   +1 more source

Reversibility and Low Commitment to Forward Catalysis in the Conjugation of Lipid Alkenals by Glutathione Transferase A4-4. [PDF]

Biomolecules, 2023
Scian M, Paço L, Murphree TA, Shireman LM, Atkins WM.   +4 more
europepmc   +1 more source

An all‐in‐one fucosylated gold nanocluster probe enables NIR‐II imaging and multi‐mechanistic therapy of acute kidney injury

BMEMat, EarlyView.
This study developed a fucoside‐targeted gold nanocluster probe that enables early NIR‐II imaging and multi‐mechanistic therapy for acute kidney injury, effectively mitigating oxidative stress, modulating inflammatory responses, and inhibiting ferroptosis to improve renal outcomes. Abstract Acute kidney injury (AKI) remains a life‐threatening condition
Ping Zhang, Boning Tan, Suqing Feng, Beibei Gu, Ting Feng, Haiguang Zhu, Jianping Xie, Xun Yuan   +7 more
wiley   +1 more source

Monocarbonyl Curcumin Analogues as Potent Inhibitors against Human Glutathione Transferase P1-1. [PDF]

Antioxidants (Basel), 2022
Pantiora P, Furlan V, Matiadis D, Mavroidi B, Perperopoulou F, Papageorgiou AC, Sagnou M, Bren U, Pelecanou M, Labrou NE.   +9 more
europepmc   +1 more source